Publications
Detailed Information
Estrogen Receptor-1 Genetic Polymorphisms for the Risk of Premature Ovarian Failure and Early Menopause
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yang, Jae Jeong | - |
dc.contributor.author | Cho, Lisa Y. | - |
dc.contributor.author | Lim, Yun Jeong | - |
dc.contributor.author | Ko, Kwang-Pil | - |
dc.contributor.author | Kim, Hyeongsu | - |
dc.contributor.author | Chang, Soung Hoon | - |
dc.contributor.author | Park, Sue K. | - |
dc.contributor.author | Yim, Sung Vin | - |
dc.contributor.author | Lee, Kun-Sei | - |
dc.date.accessioned | 2012-06-08T06:37:55Z | - |
dc.date.available | 2012-06-08T06:37:55Z | - |
dc.date.issued | 2010-02 | - |
dc.identifier.citation | JOURNAL OF WOMENS HEALTH; Vol.19 2; 297-304 | ko_KR |
dc.identifier.issn | 1540-9996 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76910 | - |
dc.description.abstract | Background: The aim of this study was to investigate the role of the estrogen receptor 1 (ESR1) genetic polymorphisms for early menopause that was classified as premature ovarian failure (POF) and early menopause (EM) and to examine whether the associations of ESR1 genetic variants are different for POF and EM. Methods: We selected 100 POF cases and matched 100 EM cases and 200 normal menopause (NM) controls from the Korean Multi-Center Cohort. Among them, we restricted idiopathic POF and EM cases vs NM controls by excluding POF/EM cases with medical/surgical causes. The XbaI (rs9340799) and PvuII (rs2234693) in the ESR1 gene were genotyped. The single-nucleotide polymorphism (SNP) and haplotype effects were analyzed by multivariate logistic regression and haplotype analysis. Also nominal polytomous logistic regression was used to find whether ESR1 genetic variants are differently associated with POF and EM. Results: The global p values for idiopathic POF and EM were 0.08 and 0.39 (SNP-based), and <0.001 and 0.12 (haplotype-based), respectively. The XbaI genetic variant containing the X allele was marginally significantly associated with a reduced risk of idiopathic POF (OR=0.6, 95% CI 0.3-1.0). The P-x haplotype and diplotypes significantly decreased the risk of idiopathic POF (OR=0.5, 95% CI 0.2-0.9; OR 0.4, 95% CI 0.2-0.9, respectively). In contrast from POF, the P-x haplotypes and diplotypes insignificantly increased the risk for both idiopathic EM (p(polytomous)=0.009 for P-x haplotype; p(polytomous)=0.02 for P-x diplotypes). Conclusion: Our results suggest that the ESR1 gene including PvuII and XbaI polymorphisms may modify the risk of idiopathic premature ovarian failure (POF) but not idiopathic early menopause (EM) risk. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | MARY ANN LIEBERT INC | ko_KR |
dc.title | Estrogen Receptor-1 Genetic Polymorphisms for the Risk of Premature Ovarian Failure and Early Menopause | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 양재정 | - |
dc.contributor.AlternativeAuthor | 임윤정 | - |
dc.contributor.AlternativeAuthor | 고광필 | - |
dc.contributor.AlternativeAuthor | 이건세 | - |
dc.contributor.AlternativeAuthor | 김형수 | - |
dc.contributor.AlternativeAuthor | 임성빈 | - |
dc.contributor.AlternativeAuthor | 장성훈 | - |
dc.contributor.AlternativeAuthor | 박수경 | - |
dc.identifier.doi | 10.1089/jwh.2008.1317 | - |
dc.citation.journaltitle | JOURNAL OF WOMENS HEALTH | - |
dc.description.citedreference | Bretherick KL, 2008, FERTIL STERIL, V89, P318, DOI 10.1016/j.fertnstert.2007.03.008 | - |
dc.description.citedreference | Chang SH, 2007, MATURITAS, V58, P19, DOI 10.1016/j.maturitas.2007.04.001 | - |
dc.description.citedreference | Kitamura I, 2007, BONE, V40, P1623, DOI 10.1016/j.bone.2007.02.016 | - |
dc.description.citedreference | Molvarec A, 2007, HYPERTENS RES, V30, P205 | - |
dc.description.citedreference | Hsieh YY, 2007, MOL HUM REPROD, V13, P117, DOI 10.1093/molehr/gal099 | - |
dc.description.citedreference | Dvornyk V, 2006, MATURITAS, V54, P19, DOI 10.1016/j.maturitas.2005.08.005 | - |
dc.description.citedreference | Onland-Moret NC, 2005, CANCER CAUSE CONTROL, V16, P1195, DOI 10.1007/s10552-005-0307-5 | - |
dc.description.citedreference | Popat RA, 2005, NEUROLOGY, V65, P383 | - |
dc.description.citedreference | Schuit SCE, 2005, EUR J ENDOCRINOL, V153, P327, DOI 10.1530/eje.1.01973 | - |
dc.description.citedreference | Kok HS, 2005, HUM REPROD, V20, P536, DOI 10.1093/humrep/deh600 | - |
dc.description.citedreference | Ioannidis JPA, 2004, JAMA-J AM MED ASSOC, V292, P2105 | - |
dc.description.citedreference | van der Klift M, 2004, J BONE MINER RES, V19, P1172, DOI 10.1359/JBMR.040215 | - |
dc.description.citedreference | Schuit SCE, 2004, JAMA-J AM MED ASSOC, V291, P2969 | - |
dc.description.citedreference | Wasserman L, 2004, INT J OBESITY, V28, P49, DOI 10.1038/sj.ijo.0802481 | - |
dc.description.citedreference | van Meurs JBJ, 2003, HUM MOL GENET, V12, P1745, DOI 10.1093/hmg/ddg176 | - |
dc.description.citedreference | Gorai I, 2003, J CLIN ENDOCR METAB, V88, P799, DOI 10.1210/jc.2002-020353 | - |
dc.description.citedreference | Laml T, 2002, HUM REPROD UPDATE, V8, P483 | - |
dc.description.citedreference | Herrington DM, 2002, CIRCULATION, V105, P1879, DOI 10.1161/01.CIR.0000016173.98826.88 | - |
dc.description.citedreference | Kobayashi N, 2002, MATURITAS, V41, P193 | - |
dc.description.citedreference | YOO KY, 2002, ASIAN PAC J CANCER P, V3, P85 | - |
dc.description.citedreference | de Bruin JP, 2001, HUM REPROD, V16, P2014 | - |
dc.description.citedreference | Pelletier G, 2000, J CLIN ENDOCR METAB, V85, P4835 | - |
dc.description.citedreference | Weiderpass E, 2000, CARCINOGENESIS, V21, P623 | - |
dc.description.citedreference | Yan G, 2000, J WOMEN HEALTH GEN-B, V9, P275 | - |
dc.description.citedreference | Lorentzon M, 1999, J CLIN ENDOCR METAB, V84, P4597 | - |
dc.description.citedreference | Weel AEAM, 1999, J CLIN ENDOCR METAB, V84, P3146 | - |
dc.description.citedreference | Drummond AE, 1999, MOL CELL ENDOCRINOL, V151, P57, DOI 10.1016/S0303-7207(99)00038-6 | - |
dc.description.citedreference | Christin-Maitre S, 1998, MOL CELL ENDOCRINOL, V145, P75 | - |
dc.description.citedreference | Torgerson DJ, 1997, EUR J OBSTET GYN R B, V74, P63 | - |
dc.description.citedreference | vanderSchouw YT, 1996, LANCET, V347, P714 | - |
dc.description.citedreference | Kobayashi S, 1996, J BONE MINER RES, V11, P306 | - |
dc.description.citedreference | NELSON LM, 1996, REPROD ENDOCRINOLOGY, P1394 | - |
dc.description.citedreference | KAPRIO J, 1995, HUM BIOL, V67, P739 | - |
dc.description.citedreference | CRAMER DW, 1995, FERTIL STERIL, V64, P740 | - |
dc.description.citedreference | EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921 | - |
dc.description.citedreference | NELSON LM, 1994, J CLIN ENDOCR METAB, V79, P1470 | - |
dc.description.citedreference | CAPLAN GA, 1994, J ROY SOC MED, V87, P200 | - |
dc.description.citedreference | PALMER JR, 1992, AM J EPIDEMIOL, V136, P408 | - |
dc.description.citedreference | BAGUR AC, 1992, CALCIFIED TISSUE INT, V51, P4 | - |
dc.description.citedreference | FRANCESCHI S, 1991, INT J CANCER, V49, P57 | - |
dc.description.citedreference | MEYER JM, 1991, AM J MED GENET, V39, P148 | - |
dc.description.citedreference | TRELOAR SA, 1990, AM J HUM GENET, V47, P137 | - |
dc.description.citedreference | SNOWDON DA, 1989, AM J PUBLIC HEALTH, V79, P709 | - |
dc.description.tc | 3 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.